Giacomini, Arianna
Turati, Marta
Grillo, Elisabetta
Rezzola, Sara
Ghedini, Gaia Cristina
Schuind, Ander Churruca
Foglio, Eleonora
Maccarinelli, Federica
Faletti, Jessica
Filiberti, Serena
Chambery, Angela
Valletta, Mariangela
Melocchi, Laura
Gofflot, Stephanie
Chiavarina, Barbara
Turtoi, Andrei
Presta, Marco
Ronca, Roberto
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (ID. 18493, AIRC IG 2019 – ID.23151)
Article History
Received: 16 March 2023
Accepted: 4 September 2023
First Online: 25 September 2023
Declarations
:
: The authors declare no competing interests.
: Animal Experiments were performed according to the Italian laws (D.L. 116/92 and following additions) that enforce the EU 86/109 Directive and were approved by the local animal ethics committee (OPBA, Organismo Preposto al Benessere degli Animali, Università degli Studi di Brescia, Italy). Breast cancer samples were obtained from the institutional biobank of the University Hospital Liege Belgium, following the approval of the institutional ethical committee (reference number 2009/69). According to Belgian law, patients obtained the information that the residual material could be used for research purpose and the consent is presumed as long as the patient does not oppose (opting-out).
: Not applicable.